This provider's $23.3M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 144% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 107% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $508.05 | $96.11 | 5.29x | $411.94 | $1.2M | 12.2K | 2.5K |
| 2017 | $351.02 | $89.27 | 3.93x | $261.75 | $2.4M | 21.5K | 5.9K |
| 2018 | $417.40 | $165.15 | 2.53x | $252.25 | $4.1M | 21.9K | 5.6K |
| 2019 | $300.00 | $153.07 | 1.96x | $146.93 | $3.7M | 20.6K | 7.2K |
| 2020 | $249.86 | $127.78 | 1.96x | $122.08 | $1.9M | 11.7K | 7.5K |
| 2021 | $206.90 | $106.49 | 1.94x | $100.41 | $3.6M | 32.1K | 20.5K |
| 2022 | $210.82 | $108.31 | 1.95x | $102.51 | $3.4M | 33.5K | 20.1K |
| 2023 | $244.80 | $119.11 | 2.06x | $125.69 | $2.9M | 16.3K | 10.6K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 51.7K | $11.0M | $212.04 | 2.77x |
| G0482 | Drug test def 15-21 classes | 37.3K | $7.1M | $191.62 | 2.21x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20.8K | $1.6M | $77.20 | 2.58x |
| 80307 | Testing for presence of drug | 25.6K | $1.5M | $58.85 | 2.58x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.4K | $529.6K | $154.55 | 1.94x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 18.0K | $447.2K | $24.86 | 2.01x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.1K | $346.1K | $113.34 | 1.76x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 5.5K | $257.9K | $47.28 | 5.48x |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 1.7K | $235.2K | $139.78 | 1.79x |
| 87636 | Sarscov2 & inf a&b amp prb | 1.3K | $176.6K | $140.29 | 1.78x |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 518 | $26.0K | $50.28 | 3.96x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 795 | $18.6K | $23.45 | 2.13x |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 326 | $6.5K | $19.98 | 1.00x |
| 83992 | PCP drug level | 92 | $1.8K | $19.77 | 4.25x |
This provider submits charges 2.54 times higher than what Medicare actually pays.
A markup ratio of 2.54x means for every $100 Medicare pays, this provider initially charges $254. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in MI for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Vpa Pc | Troy, MI | $119.3M | ✓ Clear |
| Biotech Clinical Laboratories Inc | Novi, MI | $89.7M | ✓ Clear |
| Orchard Laboratories Corp | West Bloomfield, MI | $78.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data